Cargando…
A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation
PURPOSE: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Ligh...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874553/ https://www.ncbi.nlm.nih.gov/pubmed/27257391 http://dx.doi.org/10.2147/CCID.S100697 |
_version_ | 1782433054853169152 |
---|---|
author | Nikolis, Andreas Bernstein, Steven Kinney, Brian Scuderi, Nicolo Rastogi, Shipra Sampalis, John S |
author_facet | Nikolis, Andreas Bernstein, Steven Kinney, Brian Scuderi, Nicolo Rastogi, Shipra Sampalis, John S |
author_sort | Nikolis, Andreas |
collection | PubMed |
description | PURPOSE: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Light-emitting diode (LED) photorejuvenation is a novel nonablative technique that induces collagen synthesis through biophotomodulatory pathways. MATERIALS AND METHODS: A single-center, randomized, single-blinded, placebo-controlled, split-faced clinical trial was designed. Thirty-two patients were enrolled for a 12-week study. Patients were randomized into one of four groups: Group A, treatment with KLOX-001 gel formulation and white LED (placebo) light; Group B, treatment with a placebo/base gel (no active chromophore) formulation and KLOX LED light; Group C, treatment with KLOX-001 gel formulation and KLOX LED light; and Group D, treatment with the standard skin rejuvenating treatment (0.1% retinol-based cream). Patients received treatment at weeks 0, 1, 2, and 3, and returned to the clinic at weeks 4, 8, and 12 for clinical assessments performed by an independent, blinded committee of physicians using subjective clinician assessment scales. Tolerability, adverse outcomes, and patient satisfaction were also assessed. RESULTS: Analysis demonstrated that the KLOX LED light with KLOX placebo/base gel and the KLOX LED light + KLOX-001 gel formulation groups were superior to standard of care and KLOX-001 gel formulation with placebo light on subjective clinical assessment and multiple wrinkle scales, with statistically significant results obtained for brow positioning, perioral wrinkling, and total wrinkle score. CONCLUSION: The study results show that KLOX LED light with KLOX-001 gel formulation and KLOX LED light with KLOX placebo/base gel are effective, safe, well-tolerated, and painless treatment modalities for skin rejuvenation. |
format | Online Article Text |
id | pubmed-4874553 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48745532016-06-02 A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation Nikolis, Andreas Bernstein, Steven Kinney, Brian Scuderi, Nicolo Rastogi, Shipra Sampalis, John S Clin Cosmet Investig Dermatol Clinical Trial Report PURPOSE: Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Light-emitting diode (LED) photorejuvenation is a novel nonablative technique that induces collagen synthesis through biophotomodulatory pathways. MATERIALS AND METHODS: A single-center, randomized, single-blinded, placebo-controlled, split-faced clinical trial was designed. Thirty-two patients were enrolled for a 12-week study. Patients were randomized into one of four groups: Group A, treatment with KLOX-001 gel formulation and white LED (placebo) light; Group B, treatment with a placebo/base gel (no active chromophore) formulation and KLOX LED light; Group C, treatment with KLOX-001 gel formulation and KLOX LED light; and Group D, treatment with the standard skin rejuvenating treatment (0.1% retinol-based cream). Patients received treatment at weeks 0, 1, 2, and 3, and returned to the clinic at weeks 4, 8, and 12 for clinical assessments performed by an independent, blinded committee of physicians using subjective clinician assessment scales. Tolerability, adverse outcomes, and patient satisfaction were also assessed. RESULTS: Analysis demonstrated that the KLOX LED light with KLOX placebo/base gel and the KLOX LED light + KLOX-001 gel formulation groups were superior to standard of care and KLOX-001 gel formulation with placebo light on subjective clinical assessment and multiple wrinkle scales, with statistically significant results obtained for brow positioning, perioral wrinkling, and total wrinkle score. CONCLUSION: The study results show that KLOX LED light with KLOX-001 gel formulation and KLOX LED light with KLOX placebo/base gel are effective, safe, well-tolerated, and painless treatment modalities for skin rejuvenation. Dove Medical Press 2016-05-13 /pmc/articles/PMC4874553/ /pubmed/27257391 http://dx.doi.org/10.2147/CCID.S100697 Text en © 2016 Nikolis et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Clinical Trial Report Nikolis, Andreas Bernstein, Steven Kinney, Brian Scuderi, Nicolo Rastogi, Shipra Sampalis, John S A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation |
title | A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation |
title_full | A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation |
title_fullStr | A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation |
title_full_unstemmed | A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation |
title_short | A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation |
title_sort | randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of klox-001 gel formulation with klox light-emitting diode light on facial rejuvenation |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874553/ https://www.ncbi.nlm.nih.gov/pubmed/27257391 http://dx.doi.org/10.2147/CCID.S100697 |
work_keys_str_mv | AT nikolisandreas arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT bernsteinsteven arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT kinneybrian arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT scuderinicolo arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT rastogishipra arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT sampalisjohns arandomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT nikolisandreas randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT bernsteinsteven randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT kinneybrian randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT scuderinicolo randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT rastogishipra randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation AT sampalisjohns randomizedplacebocontrolledsingleblindedsplitfacedclinicaltrialevaluatingtheefficacyandsafetyofklox001gelformulationwithkloxlightemittingdiodelightonfacialrejuvenation |